Home HIV FAQ My Amedeo About Flying Publisher   

Amedeo Prize 2008
The 21 Finalists


  Urinary Tract Infection

  Free Subscription


Articles published in Int J Antimicrob Agents

Retrieve available abstracts of 47 articles:
HTML format



Single Articles


    February 2008
  1. NICOLLE L , Funfstuck R, Matsumoto T, Naber KG, et al
    Urinary Tract Infections Supplement: International Symposia on Urinary Tract Infection, Weimar and Munich, Germany. Preface.
    Int J Antimicrob Agents. 2008;31 Suppl 1:S1.
    PubMed     Related articles   



  2. Proceedings of two international symposia on urinary tract infection organised by the Commission for Urinary Tract Infection of the International Society of Chemotherapy for Infection and Cancer. June 23-24, 2006, Weimar, Germany and March 30-April 3, 20
    Int J Antimicrob Agents. 2008;31 Suppl 1:S1-116.
    PubMed     Related articles   



  3. Masaaki Ohkoshi Award.
    Int J Antimicrob Agents. 2008;31 Suppl 1:S2-3.
    PubMed     Related articles   


  4. LYEROVA L , Viklicky O, Nemcova D, Teplan V, et al
    The incidence of infectious diseases after renal transplantation: a single-centre experience.
    Int J Antimicrob Agents. 2008;31 Suppl 1:S58-62.
    PubMed     Related articles    Abstract available


  5. MARX G , Reinhart K
    Urosepsis: from the intensive care viewpoint.
    Int J Antimicrob Agents. 2008;31 Suppl 1:S79-84.
    PubMed     Related articles    Abstract available


  6. ARISOY M , Rad AY, Akin A, Akar N, et al
    Relationship between susceptibility to antimicrobials and virulence factors in paediatric Escherichia coli isolates.
    Int J Antimicrob Agents. 2008;31 Suppl 1:S4-8.
    PubMed     Related articles    Abstract available


  7. VRANES J , Marijan T, Bedenic B, Mlinaric-Dzepina A, et al
    Clonal dissemination of highly virulent extended-spectrum beta-lactamase-producing Escherichia coli strains isolated from the urine of non-hospitalised patients in Zagreb region.
    Int J Antimicrob Agents. 2008;31 Suppl 1:S19-24.
    PubMed     Related articles    Abstract available


    December 2007
  8. GEERLINGS SE
    Urinary tract infections in patients with diabetes mellitus: epidemiology, pathogenesis and treatment.
    Int J Antimicrob Agents. 2007;.
    PubMed     Related articles    Abstract available


    November 2007
  9. NICOLLE LE
    Short-term therapy for urinary tract infection: success and failure.
    Int J Antimicrob Agents. 2007;.
    PubMed     Related articles    Abstract available


  10. TENKE P , Kovacs B, Naber KG
    Optimal management and prevention of catheter-associated urinary tract infections.
    Int J Antimicrob Agents. 2007;.
    PubMed     Related articles    Abstract available


  11. WAGENLEHNER FM , Niemetz AH, Weidner W, Naber KG, et al
    Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005.
    Int J Antimicrob Agents. 2007;.
    PubMed     Related articles    Abstract available


  12. WAGENLEHNER FM , Weidner W, Naber KG
    Optimal management of urosepsis from the urological perspective.
    Int J Antimicrob Agents. 2007;30:390-7.
    PubMed     Related articles    Abstract available


    October 2007
  13. SCHERBERICH JE , Hartinger A
    Impact of Toll-like receptor signalling on urinary tract infection.
    Int J Antimicrob Agents. 2007;.
    PubMed     Related articles    Abstract available


  14. HA US , Cho YH
    Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections.
    Int J Antimicrob Agents. 2007;.
    PubMed     Related articles    Abstract available


    August 2007
  15. STARCIC ERJAVEC M , Rijavec M, Krizan-Hergouth V, Fruth A, et al
    Chloramphenicol- and tetracycline-resistant uropathogenic Escherichia coli (UPEC) exhibit reduced virulence potential.
    Int J Antimicrob Agents. 2007;.
    PubMed     Related articles    Abstract available


    July 2007
  16. MORRIS D , Ni Chulain M, Cormican M
    Dissemination of clonal groups of uropathogenic Escherichia coli is not a significant contributor to trimethoprim and sulfamethoxazole resistance in Galway, Ireland.
    Int J Antimicrob Agents. 2007;30:97-8.
    PubMed     Related articles   


    April 2007
  17. ALEXIOU Z , Mouktaroudi M, Koratzanis G, Papadopoulos A, et al
    The significance of compliance for the success of antimicrobial prophylaxis in recurrent lower urinary tract infections: the Greek experience.
    Int J Antimicrob Agents. 2007;.
    PubMed     Related articles    Abstract available


  18. WU TL , Chia JH, Su LH, Chiu CH, et al
    CMY-2 beta-lactamase-carrying community-acquired urinary tract Escherichia coli: genetic correlation with Salmonella enterica serotypes Choleraesuis and Typhimurium.
    Int J Antimicrob Agents. 2007;29:410-6.
    PubMed     Related articles    Abstract available


    March 2007
  19. GUALCO L , Schito AM, Schito GC, Marchese A, et al
    In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Int J Antimicrob Agents. 2007;.
    PubMed     Related articles    Abstract available


    February 2007
  20. MILLER LG , Mehrotra R, Tang AW
    Does in vitro fluoroquinolone resistance predict clinical failure in urinary tract infections?
    Int J Antimicrob Agents. 2007;.
    PubMed     Related articles   


    January 2007
  21. PULLUKCU H , Tasbakan M, Sipahi OR, Yamazhan T, et al
    Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections.
    Int J Antimicrob Agents. 2007;29:62-5.
    PubMed     Related articles    Abstract available


    October 2006
  22. HA US , Cho YH
    Catheter-associated urinary tract infections: new aspects of novel urinary catheters.
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


    September 2006
  23. YUKSEL S , Ozturk B, Kavaz A, Ozcakar ZB, et al
    Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


    August 2006
  24. KUNIN CM
    Urinary-catheter-associated infections in the elderly.
    Int J Antimicrob Agents. 2006;28 Suppl 1:S78-81.
    PubMed     Related articles    Abstract available


  25. NICOLLE LE
    Asymptomatic bacteriuria: review and discussion of the IDSA guidelines.
    Int J Antimicrob Agents. 2006;28 Suppl 1:S42-8.
    PubMed     Related articles    Abstract available



  26. Proceedings of the 9th International Symposium on Urinary Tract Infection. June 4-6, 2005. Manila, Philippines.
    Int J Antimicrob Agents. 2006;28 Suppl 1:S1-112.
    PubMed     Related articles   


    July 2006
  27. TENKE P , Kovacs B, Benko R, Ashaber D, et al
    Continuous versus intermittent levofloxacin treatment in complicated urinary tract infections caused by urinary obstruction temporarily relieved by foreign body insertion.
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


  28. UEHARA S , Monden K, Nomoto K, Seno Y, et al
    A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection.
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


  29. LEE SD , Lee SJ, Hwang TK, Yoon DK, et al
    Efficacy and safety of gatifloxacin for urinary tract infection in nonspecialized Korean urologic practice.
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


  30. FUNFSTUCK R , Ott U, Naber KG
    The interaction of urinary tract infection and renal insufficiency.
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


  31. SUNDEN F , Hakansson L, Ljunggren E, Wullt B, et al
    Bacterial interference-is deliberate colonization with Escherichia coli 83972 an alternative treatment for patients with recurrent urinary tract infection?
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


  32. MURATANI T , Matsumoto T
    Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae.
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


  33. STRATCHOUNSKI LS , Rafalski VV
    Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2.
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


  34. JOHANSEN TE , Cek M, Naber KG, Stratchounski L, et al
    Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics Data from the PEP and PEAP-studies.
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


  35. MAZZEI T , Cassetta MI, Fallani S, Arrigucci S, et al
    Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections.
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


  36. WAGENLEHNER FM , Loibl E, Vogel H, Naber KG, et al
    Incidence of nosocomial urinary tract infections on a surgical intensive care unit and implications for management.
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


    May 2006
  37. ZHANEL GG , Hisanaga TL, Laing NM, Decorby MR, et al
    Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


    April 2006
  38. NICHOL KA , Sill M, Laing NM, Johnson JL, et al
    Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America.
    Int J Antimicrob Agents. 2006;.
    PubMed     Related articles    Abstract available


  39. ARYA SC , Agarwal N, Agarwal S
    Nitrofurantoin: an effective and ignored antimicrobial.
    Int J Antimicrob Agents. 2006;27:354-5.
    PubMed     Related articles   


    March 2006
  40. NYS S , van Merode T, Bartelds AI, Stobberingh EE, et al
    Antibiotic treatment and resistance of unselected uropathogens in the elderly.
    Int J Antimicrob Agents. 2006;27:236-41.
    PubMed     Related articles    Abstract available


    October 2005
  41. ZHANEL GG , Hisanaga TL, Laing NM, Decorby MR, et al
    Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Int J Antimicrob Agents 2005;.
    PubMed     Related articles    Abstract available


    July 2005
  42. ZHIYONG Z , Xiaoju L, Yanbin L, Yao Y, et al
    Piperacillin-sulbactam versus piperacillin-tazobactam: a multicentre, randomised, single-blind, controlled clinical trial.
    Int J Antimicrob Agents 2005;26:22-7.
    PubMed     Related articles    Abstract available


    June 2005
  43. KARACA Y , Coplu N, Gozalan A, Oncul O, et al
    Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years.
    Int J Antimicrob Agents 2005;.
    PubMed     Related articles    Abstract available


    May 2005
  44. BARISIC Z , Borzic E, Kraljevic KS, Carev M, et al
    Rise in ciprofloxacin resistance in Escherichia coli from urinary tract infections from 1999-2004.
    Int J Antimicrob Agents 2005;.
    PubMed     Related articles   


    March 2005
  45. SKOV R , Frimodt-Moller N, Menday P, Espersen F, et al
    Susceptibility testing of urinary isolates of Escherichia coli to mecillinam using NCCLS methodology.
    Int J Antimicrob Agents 2005;25:198-204.
    PubMed     Related articles    Abstract available


    February 2005
  46. CEBRIAN L , Rodriguez JC, Escribano I, Cascales E, et al
    Influence of various criteria for elimination of duplicates when calculating the prevalence and antibiotic susceptibility of microorganisms associated with urinary infections.
    Int J Antimicrob Agents 2005;25:173-6.
    PubMed     Related articles    Abstract available


  47. BRIGANTE G , Luzzaro F, Perilli M, Lombardi G, et al
    Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients.
    Int J Antimicrob Agents 2005;25:157-62.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: